665 related articles for article (PubMed ID: 22217877)
1. Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives.
Cai J; Zhang S; Zheng M; Wu X; Chen J; Ji M
Bioorg Med Chem Lett; 2012 Jan; 22(2):806-10. PubMed ID: 22217877
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel thiazolyl-pyrimidines and their anticancer activity in vitro.
Shi HB; Li HB; Lu KQ; Zhu XR; Hu WX; Pei W
Arch Pharm (Weinheim); 2011 Oct; 344(10):675-83. PubMed ID: 21984017
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line.
Jung MH; Kim H; Choi WK; El-Gamal MI; Park JH; Yoo KH; Sim TB; Lee SH; Baek D; Hah JM; Cho JH; Oh CH
Bioorg Med Chem Lett; 2009 Dec; 19(23):6538-43. PubMed ID: 19857963
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activities of 2-amino-thiazole-5-carboxylic acid phenylamide derivatives.
Liu W; Zhou J; Qi F; Bensdorf K; Li Z; Zhang H; Qian H; Huang W; Cai X; Cao P; Wellner A; Gust R
Arch Pharm (Weinheim); 2011 Jul; 344(7):451-8. PubMed ID: 21598297
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel 4-benzothiazole amino quinazolines Dasatinib derivatives as potential anti-tumor agents.
Cai J; Sun M; Wu X; Chen J; Wang P; Zong X; Ji M
Eur J Med Chem; 2013 May; 63():702-12. PubMed ID: 23567960
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and in vitro antitumor evaluation of novel diaryl ureas derivatives.
Sun M; Wu X; Chen J; Cai J; Cao M; Ji M
Eur J Med Chem; 2010 Jun; 45(6):2299-306. PubMed ID: 20181414
[TBL] [Abstract][Full Text] [Related]
7. One-pot synthesis of new (1,3-thiazolo[5,4-b]pyridin-2-yl)benzenediols and their antiproliferative activities against human cancer cell lines.
Matysiak J; Karpińska MM; Niewiadomy A; Wietrzyk J; Kłopotowska D
Chem Biodivers; 2012 Jan; 9(1):48-57. PubMed ID: 22253102
[TBL] [Abstract][Full Text] [Related]
8. Design and optimization of hybrid of 2,4-diaminopyrimidine and arylthiazole scaffold as anticancer cell proliferation and migration agents.
Zhou W; Huang A; Zhang Y; Lin Q; Guo W; You Z; Yi Z; Liu M; Chen Y
Eur J Med Chem; 2015; 96():269-80. PubMed ID: 25899332
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor screening of novel 3-phenylthiazolo [4,5-d]pyrimidin-2-thione derivatives.
Becan L; Wagner E
Arzneimittelforschung; 2008; 58(10):521-8. PubMed ID: 19025063
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro evaluation of the anticancer activity of novel fluorinated thiazolo[4, 5-d]pyrimidines.
Fahmy HT; Rostom SA; Saudi MN; Zjawiony JK; Robins DJ
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):216-25. PubMed ID: 12916055
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship study of 2-(substituted benzylidene)-7-(4-fluorophenyl)-5-(furan-2-yl)-2H-thiazolo[3,2-a]pyrimidin-3(7H)-one derivatives as anticancer agents.
Selvam TP; Karthick V; Kumar PV; Ali MA
Drug Discov Ther; 2012 Aug; 6(4):198-204. PubMed ID: 23006990
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological activities of sorafenib derivatives as antitumor agents.
Yao J; He Z; Chen J; Sun W; Fang H; Xu W
Bioorg Med Chem Lett; 2012 Nov; 22(21):6549-53. PubMed ID: 23021967
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 5-(2-(phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one derivatives as potent Mnk2 inhibitors: synthesis, SAR analysis and biological evaluation.
Diab S; Teo T; Kumarasiri M; Li P; Yu M; Lam F; Basnet SK; Sykes MJ; Albrecht H; Milne R; Wang S
ChemMedChem; 2014 May; 9(5):962-72. PubMed ID: 24677692
[TBL] [Abstract][Full Text] [Related]
14. Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents.
Liang YK; Yue ZZ; Li JX; Tan C; Miao ZH; Tan WF; Yang CH
Eur J Med Chem; 2014 Sep; 84():505-15. PubMed ID: 25050882
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives.
Kassab AE; Gedawy EM
Eur J Med Chem; 2013 May; 63():224-30. PubMed ID: 23501108
[TBL] [Abstract][Full Text] [Related]
16. D-ring modified novel isosteviol derivatives: design, synthesis and cytotoxic activity evaluation.
Zhang T; Lu LH; Liu H; Wang JW; Wang RX; Zhang YX; Tao JC
Bioorg Med Chem Lett; 2012 Sep; 22(18):5827-32. PubMed ID: 22901386
[TBL] [Abstract][Full Text] [Related]
17. Substituted thiazoles VI. Synthesis and antitumor activity of new 2-acetamido- and 2 or 3-propanamido-thiazole analogs.
El-Messery SM; Hassan GS; Al-Omary FA; El-Subbagh HI
Eur J Med Chem; 2012 Aug; 54():615-25. PubMed ID: 22743242
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of benzyl 2-(1H-imidazole-1-yl) pyrimidine analogues as selective and potent Raf inhibitors.
Kim M; Lee J; Jung K; Kim H; Aman W; Ryu JS; Hah JM
Bioorg Med Chem Lett; 2014 Aug; 24(15):3600-4. PubMed ID: 24878193
[TBL] [Abstract][Full Text] [Related]
20. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
Park JH; El-Gamal MI; Lee YS; Oh CH
Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
